Timothy M. Reynolds
Queens Hospital Burton on Trent
Clinical Chemistry Department
Staffordshire
UK
Name/email consistency: high
- Down's syndrome screening: population statistic dependency of screening performance. Reynolds, T., Vranken, G., Van Nueten, J., Aldis, J. Clin. Chem. Lab. Med. (2008)
- Evaluation of Down's syndrome screening population data sets by simulation: analyser-specific parameters may be superior to meta-analysis-derived parameters. Reynolds, T.M., Vranken, G., Van Nueten, J., Aldis, J. Int. J. Clin. Pract. (2008)
- Targeted versus global approaches to the management of hypercholesterolaemia. Reynolds, T.M., Mardani, A., Twomey, P.J., Wierzbickid, A.S. J. R. Soc. Promot. Health (2008)
- Median parameters for Down's syndrome screening should be calculated using a moving time-window method. Reynolds, T.M., Aldis, J. Ann. Clin. Biochem. (2008)
- Serum uric acid, the endothelium and hypertension: an association revisited. Reynolds, T. J. Hum. Hypertens (2007)
- Can we manage demand for allergy testing by restricting requests to a small number of prime target allergens? Reynolds, T.M., Twomey, P.J. Ann. Clin. Biochem. (2007)
- Implications of method specific creatinine adjustments on General Medical Services chronic kidney disease classification. Reynolds, T.M., Twomey, P.J. J. Clin. Pathol. (2007)
- Weight correction of MoM values: which method?. Reynolds, T.M., Vranken, G., Van Nueten, J. J. Clin. Pathol. (2006)
- ACP Best Practice No 181: Chemical pathology clinical investigation and management of nephrolithiasis. Reynolds, T.M. J. Clin. Pathol. (2005)
- Concordance evaluation of coronary risk scores: implications for cardiovascular risk screening. Reynolds, T.M., Twomey, P.J., Wierzbicki, A.S. Curr. Med. Res. Opin (2004)
- The number of unexpected HbA variants may be a greater problem in routine practice than is generally realized. Reynolds, T.M., Twomey, P.J., Harvey, T.C., Green, B.N. Diabet. Med. (2004)









